BotlomleyPA: The trouble with spectroscopy papers. J Magn Res Imaging2: 1–8, 1992.
2.
PrichardJWBrassLM: New anatomical and functional imaging methods. Ann Neurol32: 395–400, 1992.
3.
Vion-DuryJMeyerhoffDJ: What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy? [editorial]. J Neurol241: 354–371, 1994.
4.
JacksonEF: In vivo magnetic resonance spectroscopy in humans: a brief review. Am J Physiologic Imag7: 146–154, 1992.
5.
AlgerJR: Spatial localization for in vivo magnetic resonance spectroscopy: concepts and commentary. In: GilliesRJ (ed): NMR in physiology and biomedicine. Academic Press, San Diego1994: 151–1673.
DuynJHGillenJ: Multisection proton MR spectroscopic imaging of the brain. Radiology188: 277–282, 1993.
8.
MillerBL: A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR in Biomedicine4: 47–52, 1991.
9.
BarkerPBBreiterSN: Quantitative proton spectroscopy of canine brain: in vivo and in vitro correlations. Magn Reson Med32: 157–163, 1994.
10.
BirkenDLOlendorfWH: N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev13: 23–31, 1989.
11.
BennerREMunroPMG: The proton NMR spectrum in acute EAE: the significance of the change in the Cho: Cr ratio. Magn Reson Med29: 737–745, 1993.
12.
RangoMSpagnoliD: Central nervous system transsynaptic effects of acute axonal injury: a 1H magnetic resonance spectroscopy study. Magn Reson Med33: 595–600, 1995.
13.
Vion-DuryJNicoliF: Reversal of brain metabolic alterations with zidovudine detected by proton localized magnetic resonance spectroscopy. Lancet345: 60–61, 1995.
14.
De StefanoNMatthewsPM: Chemical pathology of acute demyelinating lesions and its correlations with disability. Ann Neurol38: 901–909, 1995.
15.
MillerBLChangL: In vivo 1H-MRS choline: correlation with in vitro chemistry/histology. Life Sci58: 1929–1935, 1996.
16.
van der KnaapMSvan der GrondJ: Age-dependent changes in localized proton anaphosphorus MR spectroscopy of the brain. Radiology176: 509–515, 1990.
17.
BruhnHStoppeG: Cerebral metabolic alterations in normal aging and Alzheimer's dementia detected by proton magnetic resonance spectroscopy [abstract]. In: Book of abstracts. Society of Magnetic Resonance in Medicine 1992. Society of Magnetic Resonance in Medicine, Berkeley (CA)1992: 752.
18.
TedeschiGBertolinoA: Brain regional distribution pattern of metabolic signal intensities in young adults by proton magnetic resonance spectroscopic imaging. Neurology45: 1384–1391, 1995.
19.
TedeschiGRighiniA: Cerebral white matter in the centrum semiovale exhibits a larger N-acetyl signal than does gray matter in long echo time 1H-magnetic resonance spectroscopic imaging. Magn Reson Med33: 127–133, 1995.
20.
FulhamMJBizziA: Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology185: 675–686, 1992.
21.
BizziAMovsasB: Response of non-Hodgkin lynphoma to radiation therapy: early and long-term assessment with 1H MR spectroscopic imaging. Radiology194: 271–276, 1995.
22.
TedeschiGLundbomN: Increased coline signal coincides with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopic imaging study. J Neurosurg87: 516–524, 1997.
23.
TedeschiGSchiffmanR: Proton magnetic resonance spectroscopic imaging in childhood ataxia with diffuse white matter hypomielination. Neurology45: 1526–1532, 1995.
24.
SchiffmannRTedeschiG: Leukodystrophy in patients with ovarian dysgenesis. Ann Neurol41: 654–661, 1997.
25.
PosseSTedeschiG: Highspeed 1H spectroscopic imaging in human brain by echo planar spatial-spectral encoding. Magn Res Med33: 34–40, 1995.